HomeGTBP • NASDAQ
add
GT Biopharma Inc
Previous close
$2.30
Day range
$2.28 - $2.28
Year range
$1.72 - $10.66
Market cap
5.78M USD
Avg Volume
19.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.76M | 18.78% |
Net income | -3.78M | -27.45% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.95M | -71.72% |
Total assets | 4.23M | -70.00% |
Total liabilities | 5.90M | -11.02% |
Total equity | -1.67M | — |
Shares outstanding | 2.23M | — |
Price to book | -3.07 | — |
Return on assets | -171.19% | — |
Return on capital | -4,406.32% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.78M | -27.45% |
Cash from operations | -2.47M | -20.57% |
Cash from investing | 1.00K | -99.79% |
Cash from financing | 0.00 | — |
Net change in cash | -2.47M | -57.23% |
Free cash flow | -1.04M | -26,196.88% |
About
Founded
1965
Headquarters
Website
Employees
1
